Advances in current and emerging therapeutics for gestational trophoblast malignancies
| Autor: | Philip Savage |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Chemotherapy
business.industry Health Policy medicine.medical_treatment Choriocarcinoma Cancer Trophoblast Immunotherapy medicine.disease 03 medical and health sciences 0302 clinical medicine Molar pregnancy medicine.anatomical_structure 030220 oncology & carcinogenesis embryonic structures cardiovascular system medicine Cancer research Gestation Pharmacology (medical) Gestational trophoblastic neoplasia business Pharmacology Toxicology and Pharmaceutics (miscellaneous) 030217 neurology & neurosurgery circulatory and respiratory physiology |
| Zdroj: | Expert Opinion on Orphan Drugs. 7:27-36 |
| ISSN: | 2167-8707 |
| DOI: | 10.1080/21678707.2019.1559047 |
| Popis: | Introduction: Gestational Trophoblastic Neoplasia (GTN) are a group of rare malignancies arising from the cells of conception. GTN was the first metastatic cancer to be cured with chemotherapy and ... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|